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Abstract
Background: The INVESTIGATE-I study was designed to inform a future definitive randomised trial of invasive
urodynamic testing, compared to basic clinical assessment with noninvasive tests prior to surgical treatment, in
women with stress urinary incontinence or stress-predominant mixed urinary incontinence. In a pilot randomised
controlled trial, women from seven participating sites were screened, consented and randomised. Overall, 771 patients
were identified from clinic notes and correspondence as being potential recruits and were sent the Patient Information
Leaflet. Of those screened, 284 were deemed eligible, giving an overall ‘screen positive’ rate of 37 %. The numbers
screened at individual centres varied between 14 and 399; the ‘screen positive’ rate varied between 22 and 79 % and
the percentage of eligible women recruited varied between 55 and 100 %. The aim of this additional substudy was to
explore why ‘screen positive’ rates may have varied so widely between apparently similar sites.
Results: All 11 trial staff involved in screening in the seven recruiting sites were asked to evaluate a series of 20
identical vignettes, mainly based on actual general practitioner referral letters. Of the vignettes, 16 mentioned one or
more definite inclusion criteria; the remainder had possible inclusions. Four had definite exclusions; 12 had possible
exclusions. Free-text comments were sought to clarify the screeners’ decisions.
For six vignettes everyone agreed that the patient was eligible; for one all agreed she was not eligible; the breakdown
for the remainder was mixed. Free-text comments illuminated uncertainties that may have led to variability in judging
potential eligibility.
Conclusions: Variability in judgements about potential trial eligibility highlights the importance of explicit and
objective inclusion and exclusion criteria, and of agreed strategies for making judgements when information is missing.
During the development and planning of trials, vignettes might be a valuable tool for training those involved in
screening and recruiting patients, for identifying potential problems and ensuring greater consistency in the
application of eligibility criteria.
Trial registration: ISTCTN registry: ISRCTN71327395, registered on 7 June 2010.
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Background
It is unclear why some trials reach recruitment targets
more easily than others [1]. Some factors have been
shown to be associated with more successful recruit-
ment; for example, the research question itself (e.g.
being a cancer or a drug trial), aspects of trial organisa-
tion (e.g. having a dedicated trial manager) and treat-
ment access (e.g. involving a treatment that is only
available within the trial) [2]. Other strategies, such as
newsletters and mail shots, have been employed to
encourage recruitment, although their effectiveness has
not been established [2, 3].
The INVESTIGATE-I (INVasive Evaluation before
Surgical Treatment of Incontinence Gives Added Thera-
peutic Effect?) study was a mixed-methods feasibility
study, designed to inform the development of a defini-
tive randomised trial of invasive urodynamic testing
(IUT) (otherwise known as bladder function testing,
or cystometry), compared to basic clinical assessment
with noninvasive tests prior to surgical treatment, in
women with stress urinary incontinence (SUI) or
stress-predominant mixed urinary incontinence (MUI)
[4]. A pragmatic, multicentre randomised pilot trial
was conducted as part of the feasibility study to
investigate how well units were able to identify eli-
gible trial participants and recruit them. Initially, six
full recruiting sites contributed to the pilot trial, with
one further full site and two Patient Identification
Centres (PICs) being incorporated later in an effort to
improve recruitment. Site initiation and training visits
were carried out by the chief investigator and the trial
manager at each of the full recruiting sites.
At the trial sites a two-stage process was employed for
identification and screening of potential participants.
First, using predefined inclusion and exclusion criteria
(see ‘Methods’), research nurses scrutinised clinic data-
bases and identified potential recruits from hospital
notes and correspondence. Second, those women identi-
fied as potentially eligible were sent Patient Information
Leaflets (PILs) and invited to attend an in-person
screening clinic, at which eligibility was confirmed.
Overall, 771 patients were identified as being potential
recruits, and were sent the PILs. Of those screened in
person, 284 were deemed eligible for the trial, giving a
‘screen positive’ rate of 37 %. Despite the apparent
consistency of screening methods, and the similar size of
recruiting centres, the numbers reported on screening
logs at individual centres varied between 14 and 399,
with ‘screen positive’ rates between 22 and 79 %. The
percentage of eligible women recruited varied between
55 and 100 %. Whilst the centres screening larger num-
bers of women also recruited larger numbers (see Fig. 1),
the conversion from screening to recruitment decreased
as the screening number increased (see Fig. 2).
In view of the variations seen in screening and recruit-
ment, a quality assurance check was made with the prin-
cipal investigators (PIs) and other recruiting staff in each
unit. This confirmed that all employed similar proce-
dures in relation to screening, in adherence with that
laid out in the study protocol [5]. It was nonetheless
possible that, although procedures were standardised
and adhered to, variability in assessment of potential
eligibility amongst recruiting staff may have resulted in
variations in screening and recruitment.
Vignette-based studies have been used in many
contexts over the last 50 years to aid understanding of
phenomena across a wide range of scientific fields,
including economics and marketing, as well as experi-
mental, developmental and educational psychology [6].
Early vignette studies often used hypothetical scenarios
for non-experimental purposes, for example in medical
training and assessment [7]. Vignettes continue to be
used for training purposes in several areas, notably pro-
fessional ethics [8, 9], and have been particularly useful
in research examining professionals’ attitudes, percep-
tions, beliefs [10] and decision-making [11]. Vignette-
based studies have also been used to investigate both
clinician enrolment behaviour [12] and patients’ willing-
ness to participate in research [13, 14].
This paper reports an extension to the INVESTIGATE-I
pilot trial aimed at exploring variations in patient screen-




A vignette-based study was conducted as an extension to a
multicentre, pilot randomised controlled trial. Its aim was
to explore consistency and variability of eligibility assess-
ments made by those involved in screening hospital notes
and communications to identify patients for recruitment.
Participants and setting
All 11 trial staff (eight nurses and three doctors)
involved in screening and recruitment in the seven full
sites recruiting patients to the INVESTIGATE-I pilot
randomised trial (PICs were not included).
Materials and data collection
A set of 20 vignettes was developed that described
fictional patients who might have been considered for
the pilot trial. The vignettes were based wholly or largely
on actual general practitioner referral letters and genu-
ine patients, with identifiable information removed, and
with some modifications to ensure that the whole range
of inclusion and exclusion criteria were covered.
To be considered eligible for recruitment to the trial,
women had to fulfil all the following criteria:
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 Have a clinical diagnosis of SUI or stress
predominant MUI
 Have stated that their family is complete
 Have undergone a course of supervised pelvic floor
muscle training (PFMT) (with or without other
nonsurgical treatments for their urge symptoms)
with inadequate resolution of their symptoms
 Both the woman herself and her treating clinician
should agree that surgery is an appropriate and
acceptable next line of treatment
Additionally, any one or more of the following criteria
excluded recruitment:
 Symptomatic pelvic organ prolapse (POP) requiring
treatment
 Previous surgery for urinary incontinence (UI) or
POP
 Urodynamic investigation within the last 3 years
 Neurological disease causing UI
 Current involvement in competing research studies,
e.g. studies of investigation or treatment of UI
 Unable to give competent informed consent
Sixteen vignettes mentioned between one and three
definite inclusion criteria (SUI [numbers 2, 3, 7, 8, 13,
14, 17 and 20], stress-predominant MUI [numbers 1, 4,
5, 6, 12, 15, 16 and 18], supervised PFMT [numbers 1, 4,
5, 6, 7, 8, 14 and 16] and family complete [numbers 7, 8,
and 12]); the other four had possible inclusions (UI
but not specified as to whether stress or urgency re-
lated [numbers 11 and 19], ‘wet all the time’ [number 9],
Fig. 1 Numbers screened and recruited at individual centres. After Hilton et al. [4], reproduced under licence with permission of the authors
Fig. 2 Number and percentage recruited to trial by number screened (shown on log scale) at each centre. From Hilton et al. [4], reproduced
under licence with permission of the authors
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PFMT mentioned but level of supervision not specified
[number 10]).
Four had one or more definite exclusions (previous
pelvic floor surgery [numbers 13 and 19]; neurological
disease [number 15], did not wish surgery [number 13],
urgency-predominant MUI [number 10]); and 12 others
contained possible exclusions (PFMT not mentioned
[numbers 2, 11, 12, 19] or not supervised [numbers 3, 9,
18 and 20], POP of uncertain significance [numbers 5
and 12], symptoms suggestive of overactive bladder
(OAB) [numbers 17 and 18] or previous treatments for
OAB [numbers 6, 9 and 16]).
Participants were circulated with an invitation to
take part and a brief description of the proposed
study (Additional file 1), the set of 20 vignettes
(Additional file 2) and a score sheet (Additional file 3), were
distributed through the web-based trial management site.
Participants were asked to assess the vignettes inde-
pendently and indicate using the score sheet whether
they would have considered the woman described in
each to be potentially eligible for recruitment into the
INVESTIGATE-I pilot trial. They were also asked to
indicate whether their judgements were clear-cut or bor-
derline, to provide information about the inclusion or
exclusion criteria that informed their decisions and to
make additional free-text comments as appropriate.
Analysis
Each participant’s responses regarding whether each
woman may be eligible were transformed into one of four
possibilities in an ordinal scale: clear-cut ‘Yes’ (Y); border-
line ‘Yes’ (?Y); borderline ‘No’ (?N); or clear-cut ‘No’ (N).
All participants’ responses were summated to a majority
grade within this four-point scale, and then rationalised to
a majority ‘Y’ or ‘N’ grading. The majority decision was
defined as one in which the percentage ‘Yes’ grading was
above or below 50 %, irrespective of whether the decisions
were considered to be clear-cut or borderline. An ‘expert’
protocol authors’ grading was also established for each
vignette. Analysis was by descriptive statistics.
Results
Each screener’s grading for the various vignettes is
shown in Table 1. For six vignettes everyone agreed that
the patient was eligible (percentage ‘Yes’ = 100 %); for
one all agreed that the patient was not eligible (percent-
age ‘Yes’ = 0 %); the grade breakdown for the remainder
was mixed, with percentage ‘Yes’ ranging from 9 to
91 %. The rates of ‘Yes’ or borderline ‘Yes’ judgements
made by individual participants ranged from 45 to 80 %.
For 14 out of the 20 vignettes, the majority decision was
‘Yes’. Although there were three vignettes for which there
was disparity between the majority screeners’ grading and
the experts’ grading in ‘clear-cut’ versus ‘borderline’
categorisation, there were no disparities in ‘Yes’ versus ‘No’
categorisation. This combined majority/expert ‘Yes/No’
categorisation was looked on as definitive and used in sub-
sequent analysis.
There were 34 occasions on which one or more indi-
vidual screeners ‘disagreed’ with the definitive categor-
isation. The number of ‘disagreements’ varied across the
11 screeners, ranging from 1–7/20 vignettes. Table 1
reports these separately as occasions on which the
screener said ‘Yes’ when the definitive view was ‘No’, and
those on which the screener said ‘No’ when the defini-
tive view was ‘Yes’. The former judgement might be con-
sidered to be erring on the side of over-inclusiveness at
the screening stage and was seen on 14 occasions; the
latter judgement, erring on the side of over-exclusiveness,
was seen on 20 occasions.
Ten of the eleven screeners made a total of 92
additional free-text comments to explain their judge-
ments. The majority of comments related to missing
information, most commonly whether PFMT had been
undertaken at all, or whether it had been supervised.
Although several screeners erred on the side of inclu-
siveness where such uncertainty existed (see Table 2), in
some instances participants’ judgements about possible
eligibility implied that they had taken the view that it
had not been done rather than ‘might have been done’
(see Table 3). Other comments related to lack of clarity
in the referral vignettes. For example, a number com-
mented on reports of vaginal laxity or dragging sensa-
tion, although information about clinical findings in
relation to POP was either missing or was negative (see
Table 4). In some instances, participants’ judgements
about possible eligibility implied that they took the view
that these issues were the greater problem and the
incontinence less of an issue. There were also uncertain-
ties around the significance of descriptions of ‘rectal
prolapse’ (as distinct from uterovaginal prolapse) and
‘repair surgery’ (not specifying prolapse repair). Finally,
although individual participant’s judgements appeared to
be largely consistent throughout the exercise, occasional
aberrations were identified, seemingly inconsistent with
their overall level of equipoise (see Table 5).
Differences between individual screeners and individ-
ual units were seen, although no clear patterns emerged.
The rate of ‘No’ grading by screeners when the definitive
grade was ‘Yes’ is perhaps the key to understanding
recruitment. This statistic is mapped to centre recruit-
ment (see shaded rows in Table 1), although again there
was little evidence of relationship.
Discussion
Main findings
This vignette-based study revealed some interesting in-
sights into challenges and opportunities affecting the
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Table 1 Screener responses to the 20 vignettes
Vignette number Centre (A–G) and Screener (1–2)
A B C D B A E F G C F %Yes Grade breakdown Majority/
definitive
grade
1 1 1 1 2 2 1 1 1 2 2 Y Y? N? N
8 Y Y Y Y Y Y Y Y Y Y Y 100 % 11 0 0 0 Y Y
14 Y Y Y Y Y Y Y Y Y? Y Y 100 % 10 1 0 0 Y Y
17 Y Y Y Y? Y Y Y? Y Y Y Y 100 % 9 2 0 0 Y Y
4 Y Y Y? Y? Y? Y Y Y Y Y Y 100 % 8 3 0 0 Y Y
7 Y Y Y Y? Y Y? Y? Y Y Y? Y? 100 % 6 5 0 0 Y Y
1 Y? Y Y? Y? Y? Y Y? Y? Y? Y Y 100 % 4 7 0 0 Y? Y
3 Y Y Y? Y Y Y Y Y Y Y? N? 91 % 8 2 1 0 Y Y
20 Y Y Y Y Y N Y Y Y Y Y 91 % 10 0 0 1 Y Y
6 Y? Y? Y? Y? Y? Y Y? Y? Y? Y N? 91 % 2 8 1 0 Y? Y
12 Y? Y? Y Y? Y? Y? N Y? Y? Y? N 82 % 1 8 0 2 Y? Y
16 Y Y? Y Y? Y? N N? Y? Y N Y 73 % 4 4 1 2 Y/Y? Y
9 Y? Y? Y? Y? N? Y Y? N? N Y? Y? 73 % 1 7 2 1 Y? Y
2 Y Y? Y? Y? Y Y N N Y N N? 64 % 4 3 1 3 Y Y
11 Y? Y? N Y? Y? Y N Y? N N N 55 % 1 5 0 5 Y?/N Y
5 Y? N Y? Y? N? N? Y N N N N? 36 % 1 3 3 4 N N
18 N Y? N N N N? Y? Y? N Y? N 36 % 0 4 1 6 N N
19 N Y? N N? Y? Y Y N N N? N 36 % 2 2 2 5 N N
10 N? N Y? N? N? N N N N N? N? 9 % 0 1 5 5 N?/N N
13 Y? N N N? N? N? N N N N N 9 % 0 1 3 7 N N
15 N N N N N N N N N N N 0 % 0 0 0 11 N N
% Yes (Y or Y?) 80 % 80 % 75 % 75 % 70 % 65 % 65 % 65 % 60 % 60 % 45 %
‘Yes’ when majority ‘No’ 2 2 2 1 1 1 3 1 0 1 0
‘No’ when majority ‘Yes’ 0 0 1 0 1 2 4 2 2 3 5
Total ‘disagreements’ 2 2 3 1 2 3 7 3 2 4 5
Centre recruitment 37 75 20 8 75 37 15 17 50 20 17
Data are sorted vertically by the rate of positive screening (% Y) for each vignette, and horizontally by % Y for individual screeners










screening of clinical notes and correspondence for po-
tential trial recruits by multiple staff and centres. The
majority ‘Yes’ versus ‘No’ grading of participants did not
differ from the ‘definitive’ grading for any vignettes.
However, complete consensus about potential eligibility
was observed for only 7 of the 20 vignettes. Individual
participants’ rates of positive judgements about potential
eligibility varied widely, from 45 to 80 %. There were
many occasions in which individual participants’ judge-
ments differed from the definitive ‘Yes’ versus ‘No’
categorisation, with the number of disagreements ran-
ging from 1 to 7/20 amongst participants.
Response data and participants’ explanatory comments
about judging potential eligibility revealed tendencies to-
wards both ‘inclusiveness’ and ‘exclusiveness’. Tending
towards inclusiveness – judging a patient to be poten-
tially eligible when there is a likelihood that they may
be ineligible on subsequent, more detailed, in-person
screening – may seem to offer potential for maximum
recruitment. However, it was observed in the
INVESTIGATE-I pilot trial that the more inclusive
screeners were in their screening processes, the less
‘efficient’ they became on a case-by-case basis. As the
number of patients invited for more detailed
screening across sites increased, the number recruited
also increased, but the proportion recruited (as a per-
centage of those screened in detail) decreased.
Both inclusiveness and exclusiveness - judging a
patient to be potentially ineligible when they may be
potentially eligible – may lead to potentially eligible
patients not being invited to take part in a trial, and thus
a theoretical potential for biasing the trial sample.
Deciding upon a preferred approach in screening may
ultimately be influenced by the resources available, and
by the nature and burden of more detailed screening on
research staff and patients. Limiting invitations for de-
tailed screening to those patients who the screeners are
more confident will be eligible may reduce both time
spent in screening, and the proportion of patients subse-
quently found to be ineligible.
Implications of findings
Variability amongst research sites and staff in judge-
ments about potentially eligibility or differences in the
application of inclusion and exclusion criteria are not
the only factors that may result in difference in recruit-
ment between sites, and no association was found in this
study between participants’ tendencies towards inclu-
siveness and increased recruitment rates in their sites
during the INVESTIGATE-I pilot trial. Other factors,
such as differences in researchers’ experience, network
of contacts, available time, and competing research pres-
sures, may play a role. However, variability in the applica-
tion of inclusion and exclusion criteria in the screening of
trial participants has been observed in previous studies
and has implications for the validity of a trial. A recent
paper by Hubbard et al. reported that in a trial of cardiac
rehabilitation in patients with bowel cancer admitted for
surgery, the research nurse at one site screened a lower
percentage of patients than the clinical nurse specialists
on the other sites, having deliberately only assessed those
she knew were most likely to be eligible [15]. A qualitative
study of recruitment to the EaSTeR trial in early laryngeal
cancer, found variability across surgeons in their applica-
tion of inclusion and exclusion criteria, leading to
Table 4 Comments suggesting lack of clarity in the vignette
contributing to uncertain eligibility
Screener E1 (a low recruiting centre) excluded 7 women (4 of whom
were included by the majority), e.g. they excluded one who reported ‘a
dragging sensation’, but with no examination findings provided, on the
grounds of ‘Patient has symptoms of prolapse’ (patient 12).
Table 5 Comment suggesting inconsistency in screener’s
application of inclusion/exclusion criteria during the study
Screener G1 (a high recruiting centre) excluded only 2 women, both of
whom were included by the majority, commenting ‘Would need
urodynamics to determine the main symptom’ (patients 9 and 16).
Table 2 Comments indicating inclusiveness in the approach to
screening
Screener B1 (a high recruiting centre) excluded only 2 patients and
commented on 5 vignettes with ‘I would send info’ e.g. ‘Even though physio
isn’t mentioned, I would send info’ (patient 2); ‘Since no specific comment
that woman requesting treatment for prolapse, I would send info’ (patient 3);
‘Although sounds urge-predominant, I would send info’ (patient 6); and ‘not
enough in GP letter to exclude, so I would send info’ (patient 9).
Screener G1 (a high recruiting centre) excluded only 2 patients and
commented on 7 vignettes with ‘I would try to contact patient prior to
sending info’, e.g. ‘I would try to contact patient prior to sending info to
check predominant symptom’ (patient 1); ‘I would try to contact patient
prior to sending info to ensure no OAB symptoms’ (patient 2); ‘I would try
to contact patient prior to sending info to check prolapse not significant’
(patient 7); and ‘I would try to contact patient prior to sending info to
check has had physio’ (patient 12).
OAB overactive bladder
Table 3 Comments indicating exclusiveness in the approach to
screening
Screener F2 (a low recruiting centre) excluded 11 women (5 of whom
were included by the majority), on the grounds of missing information,
e.g. ‘Need to check notes and if documented that patient has stress
incontinence and received PFMT then would be eligible but if it is only
on patient’s say so then further investigations would be beneficial to
give a diagnosis’ (patient 3); ‘Would need to clarify what conservative
measures patient had tried, if PFMT then would be eligible if family
complete’ (patient 6); ‘No mention of PFMT and type of incontinence
would need establishing and high possibility given age of having more
children’ (patient 11).
Screener C2 (a low recruiting centre) excluded 8 women (3 of whom
were included by the majority), e.g. ‘History suggests at least some OAB
and has had urodynamics before’ (patient 16).
OAB overactive bladder, PFMT pelvic floor muscle training
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variation between trial sites in rates of eligibility and de-
creasing the number of patients recruited [16]. Hamilton
has suggested that this variability may have reflected dif-
ferences in the degree of equipoise over the study interven-
tion between PIs (Hamilton D, personal communication,
2016). Others have opined similarly, and have suggested
that a distinction be made between personal or individual
equipoise and community [4, 17] or academic equipoise
[18, 19]. Given the consistency of screener responses within
sites, it is possible that a similar effect may have been
present in our study.
Weijer et al., in a survey of oncologists, used vignettes
to explore whether subjective eligibility criteria led to
greater investigator uncertainty and greater variability in
decisions on patient inclusion [20]. Both hypotheses
were supported, with the greatest differences being in
respect of decisions that a patient was ineligible.
Ideally, it would be best to avoid such uncertainties
in the application of inclusion and exclusion criteria,
so as to reduce the potential for over-inclusiveness
and over-exclusiveness. To achieve this, it would be
appropriate to ensure that definitions in inclusion and
exclusion criteria are clarified and made as objective
as possible and that strategies are developed to deal
with initial screening data (i.e. in records or data-
bases) that are missing or unclear. The strategies
required will vary between trials, depending amongst
other things, on specific study aims. One approach
might be to develop decision-making algorithms for
screeners based on key elements of missing information,
so as to standardise when and how to seek additional
information.
This study employed a vignette-based methodology to
explore variations in screening and recruitment across a
number of sites that had been involved in a previous
trial. The methods used identified tendencies and uncer-
tainties amongst the screening staff as a whole and at an
individual level. Therefore, it seems likely that a similar
approach could be used to advantage prospectively dur-
ing trial development and planning. Donovan et al., in a
qualitative interview study of the emotional conse-
quences of equipoise on trial staff, found that training
and support promoted greater confidence in equipoise
and improved engagement and recruitment [17].
Vignette-based methods might be used in group training
and standard-setting sessions for PIs and research nurses
to identify and address areas of uncertainty in judging
possible eligibility and to agree a consistent approach to
the screening and recruitment processes across sites.
Strengths and limitations
Although vignettes have been used in a number of re-
search contexts, this is the first use of this methodology
to explore variations in screening and recruitment of
participants amongst research staff in a multicentre trial.
Despite being a feasibility pilot trial, INVESTIGATE-I
was one of the largest trials undertaken addressing this
clinical question to date. All trial staff involved in
screening in each of the study sites underwent similar
instruction in screening methods during site initiation
visits; all participated in the vignette study and returned
a fully completed score sheet.
Proponents and critics of vignette research have raised
concerns about the artificiality of vignettes [21, 22]. That is,
textual descriptions and hypothetical behaviour might not
be sufficiently representative of real-world phenomena,
leading to concerns about the validity of research findings
and conclusions based on them. The vignettes used in this
study were wholly or largely based on actual general practi-
tioner referral letters and genuine patients, and fulfilled
relevant methodological recommendations [6].
Conclusions
Variability in judgements over trial eligibility based upon
hospital records and correspondence might be reduced
by explicit and objective inclusion and exclusion criteria.
Decision-making algorithms to assist screeners make
judgements when information is missing may also im-
prove consistency between centres. During the develop-
ment and planning of trials, vignettes might be a
valuable tool for training those involved in screening
and recruiting patients, for identifying potential prob-
lems and ensuring greater consistency in the application
of eligibility criteria. This method might be particularly
applicable to the translation of feasibility studies into de-
finitive trials.
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